AMLX
#1532
Amylyx Pharmaceuticals, Inc. - Common Stock
34.7 4 USD
-0.07%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-6.56%
Variación mensual
+76.43%
Variación en los últimos 6 meses
+131.60%
Cambio anual
+277.61%
Cierres anteriores
37.1 8
Open
34.7 4
Mínimo
34.7 4
Máximo
34.7 4
Volumen
157
Financials
- Market Capitalization 3.87 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.9
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1508 |  ADPT Adaptive Biotechnologies Corporation - Common Stock | 25.19 USD | -4.73% | -1.72% | +13.47% | +45.94% | 4.02 B USD | ||
| 1518 |  TNGX Tango Therapeutics, Inc. - Common Stock | 23.34 USD | -7.67% | -1.10% | -11.46% | +253.10% | 3.94 B USD | ||
| 1533 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 40.11 USD | -3.97% | +1.08% | +12.99% | +23.11% | 3.87 B USD | ||
| 1541 |  DNLI Denali Therapeutics Inc. - Common Stock | 24.00 USD | -2.72% | -3.54% | 0.00% | +48.42% | 3.84 B USD |